Tag: Diabetes: Type II
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
Findings seen for long-term outcomes among adult patients with diabetes and obesity
Diabetes Tied to Doubled Risk for Sepsis
Smoking, high blood sugar, and other chronic conditions heighten risk
GLP-1 Receptor Agonists Improve Glycemic, Weight Outcomes in Children With T2D
Glycemic, weight, cardiometabolic outcomes improved for children and teens with obesity, prediabetes, or T2D
Cannabis Use Increases Diabetes Risk Nearly Fourfold
Authors say diabetes risk awareness needs to be integrated into substance use disorder treatment
Hormone Replacement Therapy Patches Safer Than Oral Delivery for Women With Diabetes
Oral therapy tied to increased cardiovascular risk but not for estrogen-sensitive cancers
Once-Weekly Semaglutide 7.2 mg Beats Placebo for Obesity
Second study shows 7.2 mg semaglutide leads to greater reductions in mean body weight for those with obesity, T2D
Smoking Tied to Increased Risk for Type 2 Diabetes
People with a genetic susceptibility to developing diabetes may be more vulnerable to the adverse effects of smoking
Adults With Learning Disabilities, New Diabetes Have Shorter Time to Insulin Initiation
This finding is seen despite evidence of better short-term glycemic control in this population
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
GLP-1 RAs linked to lower risk among those with type 2 diabetes and without diabetes; greater protection seen versus metformin, insulin
AI-Enabled Bundle of Sensors, Coaching Aids Type 2 Diabetes Outcomes
Significant improvements seen in glycemic control, weight loss, and de-escalation of glucose-lowering pharmacotherapy versus usual care
